£122.07

Springer - ACE Inhibitors vs ARBs: Antihypertensive Analysis

Name: Springer - ACE Inhibitors vs ARBs: Antihypertensive Analysis
Brand: Springer
Price: 122.07 GBP
Availability: InStock

General Medical Issues

It has never been this cheap. We have no record of a lower price.

£122 today · cheaper than every other day in the last 6 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 80 days • 80 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 80 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £124 (79 days, 98.8%)

Price range: £122 - £124

Price levels: 2 different prices over 80 days

Description

Explore a specialized medical literature overview focused on the comparative study of antihypertensive strategies. This publication from Springer provides a machine-generated analysis comparing Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Designed for those interested in medical and healthcare practitioner topics, the text examines the different approaches to managing blood pressure through these two specific drug classes. This literature overview offers a technical look at current antihypertensive methods, making it a relevant resource for medical study and professional reference in the field of general medical issues. By presenting a critical analysis of these strategies, the book serves as a focused academic tool for understanding the distinctions between ACE inhibitors and ARBs.

Key Features

Provides a machine-generated literature overview comparing ACE inhibitors and ARBs for blood pressure management.

Offers a critical analysis of different antihypertensive strategies used in modern medicine.

Published by Springer, a recognized name in professional and academic literature.

Focuses on the specific medical comparison between Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers.

Serves as a specialized resource for healthcare practitioners and medical study.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 9819773822
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 27 October 2025
Listed Since: 12 November 2025

Barcode

No barcode data available

Springer - ACE Inhibitors vs ARBs: Antihypertensive Analysis

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

The Renin Angiotensin System in Cardiovascular Disease: 24 (Advances in Biochemistry in Health and Disease, 24)

Angiotensin: From the Kidney to Coronavirus (Molecular Mediators in Health and Disease: How Cells Communicate)

Antihypertensive Drugs: Pharmacology, Medical Uses & Potential Side Effects

Instrumental Determination of Certain Antihypertensive Drugs

Antihypertensive Drugs

Hypertension and Cardiovascular Disease in Asia (Updates in Hypertension and Cardiovascular Protection)

The Evaluation of Beat Blocker and Calcium Antagonist Drugs: 18 (Developments in Cardiovascular Medicine, 18)

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in the United States

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China

Farmacéutico involucrado en adherencia al tratamiento antihipertensivo

Congenital heart disease in adolescents and adults: 136 (Developments in Cardiovascular Medicine, 136)

Hydrogel Base Control Release Formulation of Anti-Hypertensive Drugs: Micro & Nano Particles of Anti-Hypertensive Drugs

Hypertension Intervention Programme: Why is there a discrepancy among patients attending the intervention programme?

Aging and Heart Failure: Mechanisms and Management

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan

Contemporary Approaches to Renal Vessels Disorders: Updates and Management Strategies

Evaluation of Left Ventricular Performance in Essential Hypertension: LV Performance in Essential Hypertension

Novel Strategies and Approaches in Hypertension Therapy

Contemporary Approaches to Renal Vessels Disorders: Updates and Management Strategies

Genetics and Pathophysiology of Essential Hypertension

Experimental Production of Diseases: Heart and Circulation: 16 / 3 (Handbook of Experimental Pharmacology)

Renin-Angiotensin Aldosterone System

Secondary Hypertension (Updates in Hypertension and Cardiovascular Protection)